(TFFP) Revenue & Revenue Breakdown
Revenue Highlights
Latest Revenue (Y)
$733.87K
Latest Revenue (Q)
$193.39K
Revenue by Period
Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $733.87K | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2017-12-31 | - | - |
Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $193.39K | -70.26% |
2024-06-30 | $650.22K | 219.88% |
2024-03-31 | $203.27K | -72.30% |
2023-12-31 | $733.87K | 100.00% |
2023-09-30 | - | -100.00% |
2023-06-30 | $333.35K | 548.18% |
2023-03-31 | $51.43K | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-09-30 | - | - |
Revenue Breakdown
Revenue Breakdown by Product
Quarterly Revenue by Product
Product/Service | Sep 24 |
---|---|
Grant | $87.34K |
Latest
Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
TCRX | TScan Therapeutics | $21.05M | - |
IMNM | Immunome | $14.02M | $2.91M |
CUE | Cue Biopharma | $5.49M | $3.34M |
GANX | Gain Therapeutics | $55.18K | - |
ANEB | Anebulo Pharmaceuticals | - | - |
LTRN | Lantern Pharma | - | - |
ANTX | AN2 Therapeutics | - | - |
CGTX | Cognition Therapeutics | - | - |
ANIX | Anixa Biosciences | - | - |
INAB | IN8bio | - | - |
DRMA | Dermata Therapeutics | - | - |
QNRX | Quoin Pharmaceuticals | - | - |
ANVS | Annovis Bio | - | - |
INMB | INmune Bio | $-155.00K | - |